Abstract
Aim
In this study, we present our patients with metachronous colorectal cancer.
Patients and methods
In the period between 1990 and 2009, 670 patients with colorectal cancer were treated.
Results
Metachronous cancer was developed in 4 (0.6%) patients. The time interval between index and metachronous cancer was 28 months to 22 years (mean 146 months).
Conclusion
Metachronous colorectal cancer is a potential risk that proves the necessity of postoperative colonoscopic control of all patients with colorectal cancer.
Similar content being viewed by others
References
Cali RL, Pitsch RM, Thomson AG et al (1993) Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 36:388–393
Miller BJ, Cohen JR (2003) Gastointestinal: synchronous and metachronous colorectal cancers. J Gastroenterol Hepatol 18:457
Fukutomi Y, Moriwaki H, Nagase S et al (2002) Metachronous colon tumors: risk factors and rationale for the surveillance colonoscopy after initial polypestomy. J Cancer Res Clin Oncol 128:569–574
Nelson RL, Persky V, Turyk M (1999) Determination of factors responsible for the declining incidence of colorectal cancer. Dis Colon Rectum 42:741–752
Sonnenberg A, Delco F, Inadomi JM (2000) Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133:573–584
Conflict of interest
The authors declare that they have no conflict of interest related to the publication of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pramateftakis, M.G., Hatzigianni, P., Kanellos, D. et al. Metachronous colorectal cancer. Tech Coloproctol 14 (Suppl 1), 63–64 (2010). https://doi.org/10.1007/s10151-010-0623-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-010-0623-y